Oxurion NV (OXUR.BR)

EUR 0.09

(-4.45%)

Total Assets Summary of Oxurion NV

Oxurion NV's latest annual total assets in 2023 was 6.55 Million EUR , down -45.38% from previous year.
Oxurion NV's latest quarterly total assets in 2024 Q2 was 4.55 Million EUR , down 0.0% from previous quarter.
Oxurion NV reported annual total assets of 11.99 Million EUR in 2022, down -36.46% from previous year.
Oxurion NV reported annual total assets of 18.87 Million EUR in 2021, down -44.94% from previous year.
Oxurion NV reported quarterly total assets of 6.55 Million EUR for 2023 FY, down -45.38% from previous quarter.
Oxurion NV reported quarterly total assets of 6.55 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Total Assets Chart of Oxurion NV (2023 - 2006)

Historical Annual Total Assets of Oxurion NV (2023 - 2006)

Year	Total Assets	Total Assets Growth
2023	6.55 Million EUR	-45.38%
2022	11.99 Million EUR	-36.46%
2021	18.87 Million EUR	-44.94%
2020	34.28 Million EUR	-47.28%
2019	65.03 Million EUR	-43.39%
2018	114.86 Million EUR	-23.65%
2017	150.43 Million EUR	23.68%
2016	121.63 Million EUR	-32.03%
2015	178.94 Million EUR	-18.92%
2014	220.71 Million EUR	-18.6%
2013	271.15 Million EUR	13.37%
2012	239.17 Million EUR	85.28%
2011	129.08 Million EUR	-9.69%
2010	142.93 Million EUR	41.22%
2009	101.21 Million EUR	50.62%
2008	67.2 Million EUR	29.24%
2007	51.99 Million EUR	39.28%
2006	37.33 Million EUR	0.0%

Year	Total Assets	Total Assets Growth
2024 Q2	4.55 Million EUR	0.0%
2023 FY	6.55 Million EUR	-45.38%
2023 Q4	6.55 Million EUR	0.0%
2023 Q2	11.82 Million EUR	0.0%
2022 Q4	11.99 Million EUR	0.0%
2022 Q2	12.79 Million EUR	0.0%
2022 FY	11.99 Million EUR	-36.46%
2021 FY	18.87 Million EUR	-44.94%
2021 Q2	19 Million EUR	0.0%
2021 Q4	18.87 Million EUR	0.0%
2020 Q4	34.28 Million EUR	0.0%
2020 Q2	48.53 Million EUR	0.0%
2020 FY	34.28 Million EUR	-47.28%
2019 Q2	80.16 Million EUR	0.0%
2019 FY	65.03 Million EUR	-43.39%
2019 Q4	65.03 Million EUR	0.0%
2018 Q4	114.86 Million EUR	0.0%
2018 FY	114.86 Million EUR	-23.65%
2018 Q2	134.59 Million EUR	0.0%
2017 Q2	103.04 Million EUR	0.0%
2017 FY	150.43 Million EUR	23.68%
2017 Q4	150.43 Million EUR	0.0%
2016 FY	121.63 Million EUR	-32.03%
2016 Q4	121.63 Million EUR	0.0%
2016 Q2	166.41 Million EUR	0.0%
2015 Q2	196.27 Million EUR	0.0%
2015 FY	178.94 Million EUR	-18.92%
2015 Q4	178.94 Million EUR	0.0%
2014 Q2	245.75 Million EUR	0.0%
2014 FY	220.71 Million EUR	-18.6%
2014 Q4	220.71 Million EUR	0.0%
2013 Q2	298.29 Million EUR	0.0%
2013 FY	271.15 Million EUR	13.37%
2013 Q4	271.15 Million EUR	0.0%
2012 Q2	258.46 Million EUR	0.0%
2012 FY	239.17 Million EUR	85.28%
2012 Q4	239.17 Million EUR	0.0%
2011 Q2	133.29 Million EUR	0.0%
2011 FY	129.08 Million EUR	-9.69%
2011 Q4	129.08 Million EUR	0.0%
2010 FY	142.93 Million EUR	41.22%
2010 Q4	142.93 Million EUR	0.0%
2010 Q2	97.33 Million EUR	0.0%
2009 FY	101.21 Million EUR	50.62%
2009 Q4	101.21 Million EUR	0.0%
2008 FY	67.2 Million EUR	29.24%
2007 FY	51.99 Million EUR	39.28%
2006 FY	37.33 Million EUR	0.0%

Peer Total Assets Comparison of Oxurion NV

Name	Total Assets	Total Assets Difference
Nicox S.A.	52.98 Million EUR	87.637%
European Medical Solutions	43.75 Million EUR	85.031%
FERMENTALG	50.24 Million EUR	86.964%
argenx SE	4.11 Billion EUR	99.841%
BioSenic S.A.	9.55 Million EUR	31.478%
Celyad Oncology SA	16.28 Million EUR	59.772%
Hyloris Pharmaceuticals SA	47.68 Million EUR	86.263%
Onward Medical N.V.	43.62 Million EUR	84.987%
PHAXIAM Therapeutics S.A.	51.3 Million EUR	87.234%
Financière de Tubize SA	1.92 Billion EUR	99.659%
UCB SA	15.53 Billion EUR	99.958%